Literature DB >> 21365321

T cell recognition of weak ligands: roles of signaling, receptor number, and affinity.

Lindsay J Edwards1, Brian D Evavold.   

Abstract

T cell recognition of antigen is a crucial aspect of the adaptive immune response. One of the most common means of pathogen immune evasion is mutation of T cell epitopes. T cell recognition of such ligands can result in a variety of outcomes including activation, apoptosis and anergy. The ability of a given T cell to respond to a specific peptide-MHC ligand is regulated by a number of factors, including the affinity, on- and off-rates and half-life of the TCR-peptide-MHC interaction. Interaction of T cells with low-potency ligands results in unique signaling patterns and requires engagement with a larger number of T cell receptors than agonist ligands. This review will address these aspects of T cell interaction with weak ligands and the ways in which these ligands have been utilized therapeutically.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365321      PMCID: PMC3107861          DOI: 10.1007/s12026-011-8204-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  97 in total

1.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

Authors:  B Bielekova; B Goodwin; N Richert; I Cortese; T Kondo; G Afshar; B Gran; J Eaton; J Antel; J A Frank; H F McFarland; R Martin
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

2.  Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion.

Authors:  C Bouneaud; P Kourilsky; P Bousso
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

3.  Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling.

Authors:  D R Plas; R Johnson; J T Pingel; R J Matthews; M Dalton; G Roy; A C Chan; M L Thomas
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

4.  An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.

Authors:  R Kubota; S S Soldan; R Martin; S Jacobson
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

5.  T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinase.

Authors:  J Huang; D Tilly; A Altman; K Sugie; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

6.  NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients.

Authors:  P D Crowe; Y Qin; P J Conlon; J P Antel
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

7.  Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group.

Authors:  L Kappos; G Comi; H Panitch; J Oger; J Antel; P Conlon; L Steinman
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

8.  Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.

Authors:  H Jiao; K Berrada; W Yang; M Tabrizi; L C Platanias; T Yi
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

9.  Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism.

Authors:  S Ikagawa; S Matsushita; Y Z Chen; T Ishikawa; Y Nishimura
Journal:  J Allergy Clin Immunol       Date:  1996-01       Impact factor: 10.793

10.  T-cell-receptor affinity and thymocyte positive selection.

Authors:  S M Alam; P J Travers; J L Wung; W Nasholds; S Redpath; S C Jameson; N R Gascoigne
Journal:  Nature       Date:  1996-06-13       Impact factor: 49.962

View more
  16 in total

1.  Size matters: sequential mutations in tumorigenesis may reflect the stochastic effect of mutagen target sizes.

Authors:  Kimberly Long; Toaa Abuelenen; Libia Pava; Maya Bastille; George Blanck
Journal:  Genes Cancer       Date:  2011-10

Review 2.  The basic principles of chimeric antigen receptor design.

Authors:  Michel Sadelain; Renier Brentjens; Isabelle Rivière
Journal:  Cancer Discov       Date:  2013-04-02       Impact factor: 39.397

3.  Immune Autoregulatory CD8 T Cells Require IFN-γ Responsiveness to Optimally Suppress Central Nervous System Autoimmunity.

Authors:  Alexander W Boyden; Ashley A Brate; Laura M Stephens; Nitin J Karandikar
Journal:  J Immunol       Date:  2020-06-12       Impact factor: 5.422

Review 4.  CD4+ T Cell Subsets and Pathways to HIV Latency.

Authors:  Luis M Agosto; Andrew J Henderson
Journal:  AIDS Res Hum Retroviruses       Date:  2018-07-09       Impact factor: 2.205

5.  Cutting edge: The signals for the generation of T cell memory are qualitatively different depending on TCR ligand strength.

Authors:  Karin M Knudson; Sara E Hamilton; Mark A Daniels; Stephen C Jameson; Emma Teixeiro
Journal:  J Immunol       Date:  2013-11-15       Impact factor: 5.426

6.  Expressing Redundancy among Linear-Epitope Sequence Data Based on Residue-Level Physicochemical Similarity in the Context of Antigenic Cross-Reaction.

Authors:  Salvador Eugenio C Caoili
Journal:  Adv Bioinformatics       Date:  2016-05-04

7.  T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment.

Authors:  Keith R Miller; Akiko Koide; Brenda Leung; Jonathan Fitzsimmons; Bryan Yoder; Hong Yuan; Michael Jay; Sachdev S Sidhu; Shohei Koide; Edward J Collins
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

8.  Host and microbial factors in regulation of T cells in the intestine.

Authors:  Chang H Kim
Journal:  Front Immunol       Date:  2013-06-10       Impact factor: 7.561

9.  Quantifying biomass changes of single CD8+ T cells during antigen specific cytotoxicity.

Authors:  Thomas A Zangle; Daina Burnes; Colleen Mathis; Owen N Witte; Michael A Teitell
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

Review 10.  Primer on tumor immunology and cancer immunotherapy.

Authors:  Timothy J Harris; Charles G Drake
Journal:  J Immunother Cancer       Date:  2013-07-29       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.